On July 3, Gelunhui reported that an investor asked Jinkai Life Science Technology (301509.SZ) on the investor interaction platform, "Is it true that Jinkai will have intentions to manufacture Meaglu peptide for Novo Nordisk?" The company replied that the company is an intermediate supplier of SNAC, an oral permeation enhancer for Meaglu peptide. Please refer to the company's announcement for relevant information about the company. Do not believe rumors and unofficial information.
金凯生科(301509.SZ)：是司美格鲁肽口服渗透促进剂SNAC的“中间体供应商”
Jinkai Life Sciences (301509.SZ) is a "intermediate supplier" of SNAC, an oral permeation enhancer for Simeglestat.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.